A Dual PPAR α/γ Agonist Increases Adiponectin and Improves Plasma Lipid Profiles in Healthy Subjects

ISSN： 1174-5886

Source： Drugs in R&D, Vol.7, Iss.2, 2006-01, pp. : 99-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist: Implications for Cardiovascular Disease in Patients with Diabetes Mellitus

By Cavender Matthew A. Lincoff A. Michael

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 209-216

Adis International

Access to resources Recommend Favorite

Two Isomeric C16 Oxo-Fatty Acids from the Diatom Chaetoceros karianus Show Dual Agonist Activity towards Human Peroxisome Proliferator-Activated Receptors (PPARs) α/γ

By Moldes-Anaya Angel Sæther Thomas Uhlig Silvio Nebb Hilde I. Larsen Terje Eilertsen Hans C. Paulsen Steinar M.

Marine Drugs, Vol. 15, Iss. 6, 2017-05 ,pp. : 148-148

MDPI

Access to resources Recommend Favorite

The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist

By Su Mingzhi Cao Jiafu Huang Jin Liu Sen Im Dong Soon Yoo Jin-Wook Jung Jee H.

Marine Drugs, Vol. 15, Iss. 1, 2017-01 ,pp. : 7-7

MDPI

Access to resources Recommend Favorite

Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects

By Yasui-Furukori Norio Saito Manabu Inoue Yoshimasa Niioka Takenori Sato Yasushi Tsuchimine Shoko Kaneko Sunao

European Journal of Clinical Pharmacology, Vol. 63, Iss. 1, 2007-01 ,pp. : 51-56

Springer Publishing Company

Access to resources Recommend Favorite

Ezetimibe improves lipid profiles in diabetes and metabolic syndrome

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite